Organization | Recordati

Recordati Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4

Founded: Corregio Italy (1926)

Organization Overview

First Clinical Trial

2006

NCT00359905

First Marketed Drug

1943

methamphetamine (desoxyn)

First NDA Approval

1957

ethotoin (peganone)

Last Known Activity

2021

Timeline

NOW

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Active Ingredients

Marketed Drugs (13)

Key: Recordati (12) Acquired (1)

betaine (1996)

carglumic acid (carbaglu) (NDA)

clorazepate (tranxene) (1972 NDA)

cysteamine (cystagon) (2020)

dactinomycin (cosmegen) (1964)

ethotoin (peganone) (1957 NDA)

ibuprofen (motrin) (2006)

indomethacin (indocin) (1985)

mechlorethamine (mustargen) (1949)

methamphetamine (desoxyn) (1943)

osilodrostat (2020)

pasireotide (signifor) (2012)

succimer (chemet) (1991 NDA)

Drugs in Phase 4 Trials (4)

Key: Recordati (2) Acquired (2)

polyethylene glycol (2 trials)

silodosin (rapaflo) (2 trials)

soy isoflavones (1 trial)

vitamin c (1 trial)

Drugs in Phase 3 Trials (8)

Key: Recordati (4) Acquired (4)

citric acid (1 trial)

fexapotide (1 trial)

filgrastim (neupogen) (3 trials)

magnesium oxide (1 trial)

mercaptamine hydrochloride (1 trial)

methadone (methadose) (1 trial)

sodium picosulfate (1 trial)

tamsulosin (flomax) (2 trials)

Drugs in Phase 2 Trials (8)

Key: Recordati (7) Acquired (1)

albumin (Human) (Plasbumin) (1 trial)

betaine (1 trial)

enalapril (vasotec) (1 trial)

hemin (Panhematin) (1 trial)

lercanidipine (1 trial)

osilodrostat (2 trials)

Rec 0/0438 (1 trial)

udonitrectag (1 trial)

Drugs in Phase 1 Trials (2)

Key: Recordati (0) Acquired (2)

follitropin alfa (1 trial)

goserelin (zoladex) (1 trial)

Drugs in Other Trials (2)

lactobacillus salivarius (2 trials)

mechlorethamine (mustargen) (1 trial)

Indications

Approved Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Cancer Pain (Phase 3)

Colorectal Neoplasms (Phase 4)

Cystinosis (Phase 3)

Diabetes Mellitus (Phase 2)

Essential Hypertension (Phase 2)

Gastroparesis (Phase 2)

Hyperplasia (Phase 4)

Hypertension (Phase 2)

Keratitis (Phase 2)

Lower Urinary Tract Symptoms (Phase 3)

Prostatic Hyperplasia (Phase 4)

Signs and Symptoms (Phase 3)

Spinal Cord Injuries (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 22
# of Trial APIs: 24